H2020FP7HORIZON
Explora SRL
- Country
- ITItaly
- Defence projects
- 0
- Projects, all programmes
- 16
- As coordinator
- 2
- EU contribution (CORDIS)
- EUR 9,122,125
- Active
- 2008 to 2022
Projects
16 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| SMARTSHAPEDevelopment of a smart shape-memory sensor for biological pressure monitoring applications | HORIZON | 2022 | Participant | EUR 403,720 |
| DESTINATIONAI-enabled RNA nanotechnology DElivery SysTem for INformATION transfer into cells. | H2020 | 2021 | Participant | EUR 492,474 |
| Synbio4ArchSynthetic Biology for Architecture | H2020 | 2020 | Coordinator | EUR 100,000 |
| MIAMiRefactoring monoterpenoid indole alkaloid production in microbial cell factories | H2020 | 2019 | Participant | EUR 719,250 |
| DELIVERDELIVERy of advanced therapies for diabetes training network | H2020 | 2019 | Participant | EUR 522,999 |
| SynBio4FlavSynthetic microbial consortia-based platform for flavonoids production using synthetic biology | H2020 | 2019 | Participant | EUR 566,666 |
| ACDCArtificial Cells with Distributed Cores to Decipher Protein Function | H2020 | 2019 | Participant | EUR 729,500 |
| BioRoboostFostering Synthetic Biology standardisation through international collaboration | H2020 | 2018 | Participant | EUR 58,250 |
| TOPCAPIThoroughly Optimised Production Chassis for Advanced Pharmaceutical Ingredients | H2020 | 2017 | Participant | EUR 424,373 |
| LIARLiving Architecture | H2020 | 2016 | Participant | EUR 462,188 |
| DRIVEDiabetes Reversing Implants with enhanced Viability and long-term Efficacy | H2020 | 2015 | Participant | EUR 820,000 |
| AMCAREAdvanced Materials for Cardiac Regeneration (AMCARE) | FP7 | 2013 | Participant | EUR 744,400 |
| NEXTNano Engineering for Cross Tolerance: new approach for bioengineered, vascularised, chimeric islet transplantation in non-immunosuppressed hosts | FP7 | 2013 | Participant | EUR 1,125,385 |
| THE GRAILTissue in Host Engineering Guided Regeneration of Arterial Intimal Layer | FP7 | 2012 | Coordinator | EUR 1,436,920 |
| MAGISTERMagnetic Scaffolds for in vivo Tissue Engineering | FP7 | 2008 | Participant | EUR 336,000 |
| ETOILEBIOETHANOL PRODUCTION VIA LIGNOCELLULOSIC FERMENTATION OF OLIVE OIL RESIDUES | FP7 | 2008 | Participant | EUR 180,000 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.